← Open Payments lookup

KATIE FOLDS: Open Payments

NPI 1205416195 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$460 in 24 payments from 12 companies in 2025. Trend: 2023 $307 · 2024 $359 · 2025 $460

Food & beverage: $460
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$90
Novo Nordisk Inc3$65
Sumitomo Pharma America, Inc.3$50
PFIZER INC.3$48
ABBVIE INC.2$44
GlaxoSmithKline, LLC.2$40
Amgen Inc.2$31
Noven Therapeutics, LLC1$25
Boehringer Ingelheim Pharmaceuticals, Inc.1$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19

Products named: AIRSUPRA, GEMTESA, ELIQUIS, Wegovy, OTEZLA, QULIPTA, Xelstrym, Ozempic.

Industry payments across GA — which companies pay providers there.